Cours M Pharmaceutical Inc Canadian Securities Exchange
Actions
CA55346E2050
Recherche biotechnologique et médicale
CA 2018 | 0,75 1,03 0,68 | CA 2019 | 0,71 0,97 0,64 | Capitalisation | 3,53 M 4,82 M 3,2 M |
---|---|---|---|---|---|
Résultat net 2018 | -5 M -6,84 M -4,54 M | Résultat net 2019 | -1 M -1,37 M -907 k | VE / CA 2018 | 4 852 616 x |
Dette nette 2018 | 319 k 436 k 289 k | Dette nette 2019 | 848 k 1,16 M 769 k | VE / CA 2019 | 6 168 166 x |
PER 2018 |
-0,6
x | PER 2019 |
-1,97
x | Employés | - |
Rendement 2018 * |
-
| Rendement 2019 |
-
| Flottant | 72,04% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | - | 03/01/18 | |
Robert Payment
DFI | Director of Finance/CFO | 42 | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Donald Skeith
BRD | Director/Board Member | 69 | 01/12/14 |
William Rodgers
BRD | Director/Board Member | - | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Varia. 1 janv. | Capi. | |
---|---|---|
+22,81% | 46,81 Md | |
+46,73% | 41,29 Md | |
-1,88% | 41,37 Md | |
-6,20% | 28,87 Md | |
+11,33% | 26,06 Md | |
-21,00% | 19,13 Md | |
-1,43% | 11,96 Md | |
+30,73% | 12,39 Md | |
-0,48% | 12,08 Md |